|
|
| Pinaspasm (pinaverium bromide) / Orient Europharma (0 Trials) |
|
| pinatuzumab vedotin (RG7593) / Roche (0 Trials) |
|
| pinometostat (EPZ-5676) / Ipsen (0 Trials) |
|
| Pinorubin (pirarubicin) / Sanofi (0 Trials) |
|
| pioglitazone / Generic mfg. (92 Trials) |
|
| pioglitazone SR (AD-4833 SR) / Takeda, Zinfandel (0 Trials) |
|
| pioglitazone/glimepiride / Generic mfg. (0 Trials) |
|
| pioglitazone/metformin / Generic mfg. (1 Trials) |
|
| pioglitazone/metformin/dapagliflozin (BR3003) / Boryung Group (0 Trials) |
|
| Pip6-PMO / PepGen (0 Trials) |
|
| pipamperone/risperidone (PNB 02) / PharmaNeuroBoost (0 Trials) |
|
| PipCit (pipamperone/citalopram) / PharmaNeuroBoost (0 Trials) |
|
| PIPE-307 / Contineum Therap, J&J (0 Trials) |
|
| PIPE-505 / Pipeline Therap (0 Trials) |
|
| PIPE-791 / Contineum Therap (0 Trials) |
|
| PIPE-858 / Pipeline Therap (0 Trials) |
|
| PIpepTolDC / City of Hope (0 Trials) |
|
| piperacillin / Generic mfg. (6 Trials) |
|
| piperacillin sodium/tazobactam sodium / Generic mfg. (45 Trials) |
|
| Piqray (alpelisib) / Novartis (62 Trials) |
|
| piracetam / Generic mfg. (6 Trials) |
|
| piracetam injection / Generic mfg. (0 Trials) |
|
| pirdinenserin program / Adamed (0 Trials) |
|
| pirenzepine topical (WST-057) / WinSanTor (0 Trials) |
|
| pirepemat (IRL752) / IRLAB Therap (0 Trials) |
|
| pirfenidone / Generic mfg. (58 Trials) |
|
| pirfenidone extended release / Cipla (0 Trials) |
|
| pirfenidone inhalation (S-770108 inhalation) / Shionogi (0 Trials) |
|
| pirfenidone sustained release (EXCL-100) / Excalibur Pharma (0 Trials) |
|
| piromelatine (Neu P11) / Neurim (1 Trials) |
|
| pirotinib (KBP-5209) / Sihuan Pharmaceutical (2 Trials) |
|
| piroxicam / Generic mfg. (3 Trials) |
|
| piroxicam betadex / Generic mfg. (0 Trials) |
|
| PIT565 / Novartis (0 Trials) |
|
| pitavastatin / Generic mfg. (16 Trials) |
|
| pitrakinra pegylated formulation (AER 003) / Aerovance (0 Trials) |
|
| PittCoVacc / University of Pittsburgh (0 Trials) |
|
| pivekimab sunirine (IMGN632) / Jazz (0 Trials) |
|
| Pivlaz (clazosentan) / Idorsia, Sosei (0 Trials) |
|
| pixatimod (PG545) / Zucero Therap (1 Trials) |
|
| Pixuvri (pixantrone) / Servier (4 Trials) |
|
| Pizensy (lactitol) / Sebela (0 Trials) |
|
| pizotifen malate / Generic mfg. (2 Trials) |
|
| pizuglanstat (TAS-205) / Otsuka (0 Trials) |
|
| PJ2-01 / StemRIM (0 Trials) |
|
| PJS-539 / CoviCept Therap (0 Trials) |
|
| PK101 / PMG Pharm (0 Trials) |
|
| PK236 / Obio Pharmaceutical (0 Trials) |
|
| PKU gene therapy / American Gene Technologies (0 Trials) |
|
| PL-18 / Protelight Pharma (0 Trials) |
|
| PL-3994 / Palatin Technologies (1 Trials) |
|
| PL-3994 intravenous / Palatin Technologies (0 Trials) |
|
| PL-6983 / Palatin Technologies (0 Trials) |
|
| PL-Z / Imunon (0 Trials) |
|
| PL001 / Pell Bio-Med Techno (0 Trials) |
|
| PL225B / Piramal Phytocare (0 Trials) |
|
| PL37 / Debiopharm (1 Trials) |
|
| PL8177 / Palatin Technologies (1 Trials) |
|
| PL8331 / Palatin Technologies (0 Trials) |
|
| PL9643 / Palatin Technologies (0 Trials) |
|
| PL9654 / Palatin Technologies (0 Trials) |
|
| placenta-based cell therapy / Charite - University of Medicine Berlin, Pluri (0 Trials) |
|
| placenta-derived MMSCs / Institute of Cell Therapy (0 Trials) |
|
| placental-derived mesenchymal stem cells (PLX-MS) / Pluri (0 Trials) |
|
| placental-derived mesenchymal stem cells (PLX-STROKE) / Pluri (0 Trials) |
|
| placulumab (CEP-37247) / Teva (1 Trials) |
|
| pLADD / Novartis (0 Trials) |
|
| plague vaccine (F1+rV) / Sinopharm (0 Trials) |
|
| plamotamab (XmAb13676) / Xencor (1 Trials) |
|
| Planokuf D (cetirizine/dextromethorphan HCL/menthol/psedoephedrine HCL) / Shreya Life Sci (0 Trials) |
|
| Plant derived VLP for COVID-19 / Shiraz University (0 Trials) |
|
| plant virus nanotechnology based coronavirus vaccine / University of California (0 Trials) |
|
| plant-based ‘COVID-19’ vaccine / G+Flas Life Sci (0 Trials) |
|
| Plasbumin 5% (human albumin, 5%) / Grifols (0 Trials) |
|
| Plasbumin-25 (human albumin 25%) / Grifols (0 Trials) |
|
| plasma exchange (PLEX) / Mayo Clinic, Terumo Corp (1 Trials) |
|
| plasma-derived alpha-1 antitrypsin / Resilience (0 Trials) |
|
| plasma-derived blood coagulation factor / Liminal BioSci (0 Trials) |
|
| plasma-derived human coagulation factor IX / China Biologic Products (0 Trials) |
|
| plasma-derived human coagulation factor VIII / China Biologic Products (0 Trials) |
|
| plasma-derived human prothrombin complex concentrate / China Biologic Products (0 Trials) |
|
| plasma-derived immunoglobulin-enriched solution / Ahvaz Jundishapur University of Medical Sciences (0 Trials) |
|
| PlasmaCap IG (human immune globulin IV 10%) / Resilience (1 Trials) |
|
| Plasmanate (plasma protein fraction (human) 5%) / Grifols (0 Trials) |
|
| Plasmodium immunotherapy for cancer / CAS Lamvac Biotech (0 Trials) |
|
| Plastomitin (SkQ1 pill) / Mitotech (0 Trials) |
|
| PLB 1003 / Avistone Biotech (0 Trials) |
|
| PLB1004 / Avistone Biotech (0 Trials) |
|
| PLC / PlateletBio (0 Trials) |
|
| PLD-101 / PeLeMed (0 Trials) |
|
| PLD-102 / PeLeMed (0 Trials) |
|
| PledOx (calmangafodipir) / Egetis Therap (0 Trials) |
|
| Plegridy (PEG-interferon β-1a) / Biogen (6 Trials) |
|
| Plenaxis (abarelix) / Contura (0 Trials) |
|
| Pleneva (BGC 200134) / Boston Scientific (0 Trials) |
|
| plerixafor / Generic mfg. (28 Trials) |
|
| plerixafor/low-dose tacrolimus (MRG-001) / MedRegen (0 Trials) |
|
| PLG0206 / Peptilogics (0 Trials) |
|
| PLG0301 / Peptilogics (0 Trials) |
|
| PLG101 / PhiloGene (0 Trials) |
|
| PLG201 / PhiloGene (0 Trials) |
|
| Pliaglis (lidocaine and tetracaine topical cream 7%/7%) / Galderma (3 Trials) |
|
| Plicera (afegostat tartrate) / Amicus (0 Trials) |
|
| plinabulin (BPI 2358) / BeyondSpring (7 Trials) |
|
| Plivensia (sirukumab) / J&J (0 Trials) |
|
| plixorafenib (FORE-8394) / Fore Biotherap (2 Trials) |
|
| PLK-1 inhibitors / Sareum (0 Trials) |
|
| PLM-301 / PeLeMed (0 Trials) |
|
| PLN-101095 / Pliant Therapeutics (0 Trials) |
|
| PLN-101325 / Pliant Therapeutics (0 Trials) |
|
| PLN-1474 / Novartis (0 Trials) |
|
| plocabulin (PM184) / PharmaMar (0 Trials) |
|
| plogosertib (CYC140) / Cyclacel (1 Trials) |
|
| plonmarlimab (TJM2) / I-Mab (0 Trials) |
|
| plovamer (CO-14) / EMD Serono (1 Trials) |
|
| plozalizumab (TAK-202) / Takeda (0 Trials) |
|
| plozasiran (ARO-APOC3) / Arrowhead (0 Trials) |
|
| Plumiaz (diazepam nasal spray) / Acorda (0 Trials) |
|
| pluripotent cell‑derived cancer immunotherapy / Fate Therap (0 Trials) |
|
| Pluvicto (lutetium Lu 177 vipivotide tetraxetan) / Novartis (14 Trials) |
|
| PLX 200 / Polaryx (0 Trials) |
|
| PLX-300 / Polaryx (0 Trials) |
|
| PLX-4107 / Plexium (0 Trials) |
|
| PLX-BMT / Pluri (0 Trials) |
|
| PLX-IBD / Pluri (0 Trials) |
|
| PLX015 / ProLynx (0 Trials) |
|
| PLX038 / ProLynx (0 Trials) |
|
| PLX100 / Polaryx (0 Trials) |
|
| PLX4720 / Daiichi Sankyo (0 Trials) |
|
| PLX51107 / Daiichi Sankyo (2 Trials) |
|
| PLX5568 / Daiichi Sankyo (0 Trials) |
|
| PLX5622 / Daiichi Sankyo (0 Trials) |
|
| PM-43I / Atrapos Therap (0 Trials) |
|
| PM1003 / Biotheus (0 Trials) |
|
| PM1008 / Biotheus, Adimab (0 Trials) |
|
| PM1009 / Biotheus, Adimab (0 Trials) |
|
| PM1010 / Biotheus, Adimab (0 Trials) |
|
| PM1013 / Biotheus, Genechem (0 Trials) |
|
| PM1015 / Biotheus (0 Trials) |
|
| PM1021 / Biotheus, Adimab (0 Trials) |
|
| PM1022 / Biotheus (0 Trials) |
|
| PM1032 / Biotheus (0 Trials) |
|
| PM1038 / Biotheus (0 Trials) |
|
| PM1043 / Biotheus (0 Trials) |
|
| PM1080 / Biotheus (0 Trials) |
|
| PM1086 / Biotheus (0 Trials) |
|
| PM160057 / PharmaMar (0 Trials) |
|
| PM181108A / Piramal Phytocare (0 Trials) |
|
| PM3006 / Biotheus (0 Trials) |
|
| PM3023 / Biotheus (0 Trials) |
|
| PM4008 / Biotheus (0 Trials) |
|
| PM8001 / Biotheus (0 Trials) |
|
| PM8003 / Biotheus (0 Trials) |
|
| PMA-101R / PharmedArtis (0 Trials) |
|
| PMA-104R / PharmedArtis (0 Trials) |
|
| PMA-109R / PharmedArtis (0 Trials) |
|
| PMA-201 / PharmedArtis (0 Trials) |
|
| PMA-204 / PharmedArtis (0 Trials) |
|
| PMA-406 / PharmedArtis (0 Trials) |
|
| PMA-411R / PharmedArtis (0 Trials) |
|
| PMA-BB10 / PharmedArtis (0 Trials) |
|
| PMB-CT01 / PeproMene Bio (0 Trials) |
|
| PMC 901 (bevacizumab biosimilar) / PharmAbcine (0 Trials) |
|
| PMC-005BL / PharmAbcine (0 Trials) |
|
| PMC-122 / PharmAbcine (0 Trials) |
|
| PMC-309 / PharmAbcine (0 Trials) |
|
| PMC-401 / PharmAbcine (0 Trials) |
|
| PMC-401S / PharmAbcine (0 Trials) |
|
| PMC-402 / PharmAbcine (0 Trials) |
|
| PMC-403 / PharmAbcine (0 Trials) |
|
| PMC003 / Jiangsu Pacific Meinuoke Biopharmaceutical (0 Trials) |
|
| PMC004 / Jiangsu Pacific Meinuoke Biopharmaceutical (0 Trials) |
|
| PMC005 / Jiangsu Pacific Meinuoke Biopharmaceutical (0 Trials) |
|
| PMC006 / Jiangsu Pacific Meinuoke Biopharmaceutical (0 Trials) |
|
| PMC007 / Jiangsu Pacific Meinuoke Biopharmaceutical (0 Trials) |
|
| PMC008 / Jiangsu Pacific Meinuoke Biopharmaceutical (0 Trials) |
|
| PMD-026 / Phoenix Molecular Designs (0 Trials) |
|
| PMG-1015 / Pulmongene (0 Trials) |
|
| PMI21 / D&D Pharmatech (0 Trials) |
|
| PMN267 / ProMIS Neurosci (0 Trials) |
|
| PMN300 / ProMIS Neurosci (0 Trials) |
|
| PMN310 / ProMIS Neurosci (0 Trials) |
|
| PMN320 / ProMIS Neurosci (0 Trials) |
|
| PMN330 / ProMIS Neurosci (0 Trials) |
|
| PMN340 / ProMIS Neurosci (0 Trials) |
|
| PMN350 / ProMIS Neurosci (0 Trials) |
|
| PMN442 / ProMIS Neurosci (0 Trials) |
|
| PMR-116 / Pimera Therap (0 Trials) |
|
| PMX 53 / Teva (0 Trials) |
|
| PN 0615 / Teva (0 Trials) |
|
| PN-101 / Paean Bio (0 Trials) |
|
| PN-2034 / Sanofi (0 Trials) |
|
| PN-232 / J&J (0 Trials) |
|
| PN-943 / Protagonist Therap (0 Trials) |
|
| PN-P001 / Pleryon (0 Trials) |
|
| PN001 / Parkure (0 Trials) |
|
| PN002 / Parkure (0 Trials) |
|
| PN003 / Parkure (0 Trials) |
|
| PneumoBlast (fibroblast cell therapy) / Fibrogenesis (0 Trials) |
|
| pneumococcal recombinant vaccine (GSK 2189242A) / GSK (0 Trials) |
|
|